JP2023522615A - E型肝炎の治療のための二環式及び単環式ヌクレオシド類似体 - Google Patents
E型肝炎の治療のための二環式及び単環式ヌクレオシド類似体 Download PDFInfo
- Publication number
- JP2023522615A JP2023522615A JP2022562424A JP2022562424A JP2023522615A JP 2023522615 A JP2023522615 A JP 2023522615A JP 2022562424 A JP2022562424 A JP 2022562424A JP 2022562424 A JP2022562424 A JP 2022562424A JP 2023522615 A JP2023522615 A JP 2023522615A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- compounds
- mmol
- pharmaceutically acceptable
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026038584A JP2026120528A (ja) | 2020-04-14 | 2026-03-11 | E型肝炎の治療のための二環式及び単環式ヌクレオシド類似体 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20169480 | 2020-04-14 | ||
| EP20169480.9 | 2020-04-14 | ||
| PCT/EP2021/059504 WO2021209419A1 (en) | 2020-04-14 | 2021-04-13 | Bi- and monocyclic nucleoside analogs for treatment of hepatitis e |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026038584A Division JP2026120528A (ja) | 2020-04-14 | 2026-03-11 | E型肝炎の治療のための二環式及び単環式ヌクレオシド類似体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023522615A true JP2023522615A (ja) | 2023-05-31 |
| JP2023522615A5 JP2023522615A5 (cg-RX-API-DMAC7.html) | 2024-04-18 |
Family
ID=70289599
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022562424A Pending JP2023522615A (ja) | 2020-04-14 | 2021-04-13 | E型肝炎の治療のための二環式及び単環式ヌクレオシド類似体 |
| JP2026038584A Pending JP2026120528A (ja) | 2020-04-14 | 2026-03-11 | E型肝炎の治療のための二環式及び単環式ヌクレオシド類似体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026038584A Pending JP2026120528A (ja) | 2020-04-14 | 2026-03-11 | E型肝炎の治療のための二環式及び単環式ヌクレオシド類似体 |
Country Status (15)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024086592A2 (en) * | 2022-10-17 | 2024-04-25 | Emory Unversity | 4'-halogen containing nucleotide and nucleoside therapeutic compositions and uses related thereto |
| WO2025014360A1 (en) * | 2023-07-07 | 2025-01-16 | Erasmus University Medical Center Rotterdam | Guanosine nucleotide analogs for use in preventing and/or treating hepatitis e virus infection |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017519784A (ja) * | 2014-06-24 | 2017-07-20 | アリオス バイオファーマ インク. | 置換ヌクレオシド、ヌクレオチドおよびその類似体 |
| US20170348343A1 (en) * | 2016-06-03 | 2017-12-07 | Gilead Pharmasset Llc | Methods of treating hepatitis e viral infection |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2952714T3 (es) * | 2013-06-26 | 2023-11-03 | Janssen Pharmaceuticals Inc | Nucleósidos sustituidos, nucleótidos y análogos de los mismos |
| SG11201610597QA (en) * | 2014-06-24 | 2017-01-27 | Alios Biopharma Inc | Substituted nucleosides, nucleotides and analogs thereof |
-
2021
- 2021-04-13 KR KR1020227039015A patent/KR20230002592A/ko active Pending
- 2021-04-13 PE PE2022002242A patent/PE20230386A1/es unknown
- 2021-04-13 WO PCT/EP2021/059504 patent/WO2021209419A1/en not_active Ceased
- 2021-04-13 CN CN202180028212.9A patent/CN115515603A/zh active Pending
- 2021-04-13 AU AU2021255809A patent/AU2021255809B2/en active Active
- 2021-04-13 EP EP21716786.5A patent/EP4135715B1/en active Active
- 2021-04-13 CA CA3174790A patent/CA3174790A1/en active Pending
- 2021-04-13 JP JP2022562424A patent/JP2023522615A/ja active Pending
- 2021-04-13 AR ARP210100979A patent/AR121836A1/es unknown
- 2021-04-13 PH PH1/2022/552679A patent/PH12022552679A1/en unknown
- 2021-04-13 UY UY0001039172A patent/UY39172A/es unknown
- 2021-04-13 ES ES21716786T patent/ES2982564T3/es active Active
- 2021-04-13 MX MX2022012904A patent/MX2022012904A/es unknown
- 2021-04-13 BR BR112022020825A patent/BR112022020825A2/pt unknown
-
2022
- 2022-10-12 CL CL2022002804A patent/CL2022002804A1/es unknown
-
2026
- 2026-03-11 JP JP2026038584A patent/JP2026120528A/ja active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017519784A (ja) * | 2014-06-24 | 2017-07-20 | アリオス バイオファーマ インク. | 置換ヌクレオシド、ヌクレオチドおよびその類似体 |
| US20170348343A1 (en) * | 2016-06-03 | 2017-12-07 | Gilead Pharmasset Llc | Methods of treating hepatitis e viral infection |
Non-Patent Citations (1)
| Title |
|---|
| GASTROENTEROLOGY, vol. 150, JPN6025016427, 2016, pages 82 - 85, ISSN: 0005583714 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CA3174790A1 (en) | 2021-10-21 |
| US20230310481A1 (en) | 2023-10-05 |
| EP4135715A1 (en) | 2023-02-22 |
| CL2022002804A1 (es) | 2023-03-31 |
| AU2021255809B2 (en) | 2026-08-06 |
| CN115515603A (zh) | 2022-12-23 |
| PH12022552679A1 (en) | 2024-04-22 |
| BR112022020825A2 (pt) | 2022-11-29 |
| EP4135715B1 (en) | 2024-05-08 |
| ES2982564T3 (es) | 2024-10-16 |
| MX2022012904A (es) | 2023-01-24 |
| AU2021255809A1 (en) | 2022-12-15 |
| PE20230386A1 (es) | 2023-03-06 |
| UY39172A (es) | 2021-10-29 |
| EP4135715C0 (en) | 2024-05-08 |
| WO2021209419A1 (en) | 2021-10-21 |
| AR121836A1 (es) | 2022-07-13 |
| KR20230002592A (ko) | 2023-01-05 |
| JP2026120528A (ja) | 2026-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11267825B2 (en) | Highly active amino-thiazole substituted indole-2-carboxamides active against the hepatitis B virus (HBV) | |
| US20110171192A1 (en) | Substituted amine derivative and medicinal composition comprising same as the active ingredient | |
| BR112015020472B1 (pt) | composto de fosforamidato de nucleosídeo, composição farmacêutica e uso do mesmo | |
| EA032239B1 (ru) | Способы лечения вирусных инфекций filoviridae | |
| JP2022506337A (ja) | B型肝炎ウイルス(hbv)に対して活性を有する6,7-ジヒドロ-4h-ピラゾロ[1,5-a]ピラジンインドール-2-カルボキサミド | |
| KR20100020484A (ko) | 헤테로아릴 치환된 티아졸 그리고 항-바이러스제로서의 그들의 사용 | |
| JP2016538252A (ja) | 置換された(s)−(2r,3r,5r)−3−ヒドロキシ−(5−ピリミジン−1−イル)テトラヒドロフラン−2−イルメチルアリールホスホロアミデート | |
| RU2299202C2 (ru) | N-фениларилсульфонамид, фармацевтическая композиция, содержащая указанное соединение в качестве активного ингредиента, соединение, являющееся промежуточным в синтезе указанного соединения, и способ его получения | |
| JP2022521081A (ja) | Hbv感染若しくはhbv誘導性疾患の治療において有用なアミド誘導体 | |
| EP4135715B1 (en) | Bi- and monocyclic nucleoside analogs for treatment of hepatitis e | |
| CN115974855A (zh) | Ezh2和hdac双靶点抑制剂、其药物组合物及其制备方法和用途 | |
| CN116102553A (zh) | 一种芳香稠环亚胺类化合物及其制备方法和应用 | |
| JP2023522612A (ja) | E型肝炎の治療のためのスピロ環式ヌクレオシド類似体 | |
| HK40085931A (en) | Bi- and monocyclic nucleoside analogs for treatment of hepatitis e | |
| HK40088561B (en) | Bi- and monocyclic nucleoside analogs for treatment of hepatitis e | |
| HK40088561A (en) | Bi- and monocyclic nucleoside analogs for treatment of hepatitis e | |
| OA21046A (en) | BI- and monocyclic nucleoside analogs for treatment of hepatitis E. | |
| JP2023521425A (ja) | E型肝炎の治療のためのアルキニルヌクレオシド類似体 | |
| HK40085110A (en) | Spirocyclic nucleoside analogues for the treatment of hepatitis e | |
| CN118005694B (zh) | 一种环状核苷类似物及其制备方法和应用 | |
| CN114127078B (zh) | 杂化合物及其使用方法 | |
| HK40090491A (en) | Alkynyl nucleoside analogs for treatment of hepatitis e | |
| CN117126162A (zh) | 多取代杂环类化合物及其制备方法和应用 | |
| JP2001114689A (ja) | チロシン脱リン酸化酵素阻害剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240408 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240408 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250430 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20250717 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20250922 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251030 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20251111 |